Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.

@article{Exner1999BetaadrenergicBA,
  title={Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.},
  author={Derek V. Exner and Daniel L. Dries and Myron A. Waclawiw and Bonnie Shelton and Michael J. Domanski},
  journal={Journal of the American College of Cardiology},
  year={1999},
  volume={33 4},
  pages={916-23}
}
OBJECTIVES This analysis was performed to assess whether beta-adrenergic blocking agent use is associated with reduced mortality in the Studies of Left Ventricular Dysfunction (SOLVD) and to determine if this relationship is altered by angiotensin-converting enzyme (ACE) inhibitor use. BACKGROUND The ability of beta-blockers to alter mortality in patients with asymptomatic left ventricular dysfunction is not well defined. Furthermore, the effect of beta-blocker use, in addition to an ACE… CONTINUE READING
36 Extracted Citations
43 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 36 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 43 references

and Committees

  • CIBIS II Investigator
  • The Cardiac Insufficiency Bisoprolol Study II…
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…